C

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Vice President of Pharmacovigilance

Biology & BiotechConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA

About the Job

Requirements

  • An M.D., D.O., or M.B.B.S. is required.
  • At least 15 years of global experience in oncology drug safety within the biotechnology or pharmaceutical industry is required.
  • In-depth knowledge of FDA safety regulations, ICH Guidelines, NMPA requirements, and other global safety regulations is required.
  • A deep understanding of risks and risk-mitigation steps related to safety signals and pharmacovigilance is required.
  • Expert knowledge of safety database applications such as Veeva, ARGUS, or IQVIA and safety signal detection is required.
  • Strong leadership skills, including the ability to mentor teams and lead cross-functional initiatives, are required.
  • Excellent written, verbal, and presentation skills are required, with the ability to influence senior leadership and external stakeholders.
  • Experience in the oncology space is required.

Responsibilities

  • Lead and build the Safety and Pharmacovigilance function.
  • Establish and maintain safety and pharmacovigilance infrastructure that prioritizes safety by design in all development activities.
  • Lead pharmacovigilance activities for company products, including safety surveillance, signal detection, and risk-benefit assessments.
  • Serve as the primary contact for safety-related issues, including regulatory authority interactions and safety service provider management.
  • Provide strategic safety insights to the Chief Medical Officer and Executive Leadership Team, particularly regarding company products' risk-benefit profiles.
  • Oversee preparation and review of safety documents, including DSURs, safety reports, and clinical development documentation.
  • Serve as the primary pharmacovigilance representative in interactions with FDA, NMPA, EMA, and other global health authorities, including Type B/C meetings, health authority safety queries, and pharmacovigilance inspections.
  • Ensure compliance with global safety regulations and guidelines and lead responses to safety-related inquiries from regulatory authorities.
  • Manage the pharmacovigilance budget and resources, including internal teams and external contractors.
  • Drive continuous improvement in pharmacovigilance practices and ensure readiness for regulatory inspections and audits.
  • Collaborate with Clinical Development, Regulatory Affairs, and Quality to integrate safety considerations into company strategy.
  • Represent the company externally and build relationships with industry leaders and vendors to enhance safety and pharmacovigilance capabilities.

Desired Qualifications

  • BLA/NDA experience is highly preferred.

About the Company

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Crescent Biopharma develops oncology therapies for solid tumors, led by CR-001, a tetravalent bispecific antibody that blocks PD-1 and VEGF to boost anti-tumor immunity while inhibiting tumor blood vessel growth. CR-001 sits in a global Phase 1/2 ASCEND trial, and the pipeline also includes CR-002, an anti-PD-L1 antibody-drug conjugate, and CR-003, an ITGB6-targeted ADC. The company differentiates itself by combining immune checkpoint blockade with VEGF inhibition and other targeted modalities to build an immuno-oncology backbone for solid tumors, supported by strategic partnerships and substantial private placements. Crescent’s goal is to advance multi-agent regimens toward regulatory approval and commercial development for patients with solid tumors.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2003

Recently Posted Jobs

Explore more opportunities at Crescent Biopharma

See more jobs